Assessing Vitamin D3 in Patients with a Therosclerosis and Their Correlation with Interferon Gamma and Biochemical Markers in the Salah al-Din Governorate
Main Article Content
Abstract
The study aimed to assess vitamin D3 levels particularly interferon-gamma (IFN-γ), and their correlation with various biochemical and physiological markers. This study involved 180 males aged 45–75 years. Group1 had long-term atherosclerosis, Group 2 had recently developed atherosclerosis, Group 3 had both atherosclerosis and diabetes, and for each group (n=40), Group 4 (n=35) had atherosclerosis and were receiving vitamin D3 supplements, and Group 5 (n=25) was the healthy group. Blood samples were collected at Salah al-Din General Hospital after diagnosis by specialist doctors.
Results significant (P≤0.01) in IFN-γ levels in Groups 1, 2, and 3. Aspartate aminotransferase (AST) levels showed a significant increase (P≤0.01) in groups 2, 3, and 4. aminotransferase (ALT) levels showed a significant increase (P≤0.01) in group 2.
These findings suggest a strong association between atherosclerosis and altered IFN-γ and liver enzyme levels, indicating potential biomarkers for disease progression and treatment monitoring. Vitamin D3 plays a crucial role in preventing atherosclerosis, particularly by reducing the incidence of high-risk atherosclerotic plaques and decreasing the burden of non-calcified plaques.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Tikrit Journal of Pure Science is licensed under the Creative Commons Attribution 4.0 International License, which allows users to copy, create extracts, abstracts, and new works from the article, alter and revise the article, and make commercial use of the article (including reuse and/or resale of the article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made, and the licensor is not represented as endorsing the use made of the work. The authors hold the copyright for their published work on the Tikrit J. Pure Sci. website, while Tikrit J. Pure Sci. is responsible for appreciate citation of their work, which is released under CC-BY-4.0, enabling the unrestricted use, distribution, and reproduction of an article in any medium, provided that the original work is properly cited.
References
1. Mytych W, Bartusik-Aebisher D, Łoś A, Dynarowicz K, Myśliwiec A, Aebisher D. Photodynamic therapy for atherosclerosis. International journal of molecular sciences. 2024;25(4):1958. https://doi.org/10.3390/ijms25041958
2. Bergström G, Persson M, Adiels M, Björnson E, Bonander C, Ahlström H, et al. Prevalence of subclinical coronary artery atherosclerosis in the general population. Circulation. 2021;144(12):916-29. https://doi.org/10.1161/CIRCULATIONAHA.121.055340
3. Alradwan I, Al Fayez N, Alomary MN, Alshehri AA, Aodah AH, Almughem FA, et al. Emerging trends and innovations in the treatment and diagnosis of atherosclerosis and cardiovascular disease: a comprehensive review towards healthier aging. Pharmaceutics. 2024;16(8):1037.
https://doi.org/10.3390/pharmaceutics16081037
4. Laylani LA-A-SS. Evalution of Inhibin B and some Sexual Hormones Levels in men with Atherosclerosis Kirkuk city. Tikrit Journal of Pure Science. 2018;23(7):52-4.
https://doi.org/10.25130/tjps.v23i7.696
5. Jebari-Benslaiman S, Galicia-García U, Larrea-Sebal A, Olaetxea JR, Alloza I, Vandenbroeck K, et al. Pathophysiology of atherosclerosis. International journal of molecular sciences. 2022;23(6):3346.
https://doi.org/10.3390/ijms23063346
6. Deleskog A, Ostenson C-G. Vitamin D and aspects of cardiovascular disease. J Diabetes Metab. 2015;6(6):1000545. http://dx.doi.org/10.4172/2155-6156.1000545
7. Elyasi A, Voloshyna I, Ahmed S, Kasselman LJ, Behbodikhah J, De Leon J, Reiss AB. The role of interferon-γ in cardiovascular disease: an update. Inflammation Research. 2020;69:975-88. https://doi.org/10.1007/s00011-020-01382-6
8. Mehklef EH, Al-Hamdany WAS. Study of the Physiological effects of heart Atherosclerosis on concentrations of some electrolytes, lipid component, sex hormones in Tikrit city and its Governorate. Tikrit Journal of Pure Science. 2018;23(7):12-7. http://dx.doi.org/10.25130/tjps.26.2021.030
9. Park H-M, Lee J-H, Lee Y-J. Positive association of serum alkaline phosphatase level with severe knee osteoarthritis: a nationwide population-based study. Diagnostics. 2020;10(12):1016. https://doi.org/10.3390/diagnostics10121016
10. Roffe-Vazquez DN, Huerta-Delgado AS, Castillo EC, Villarreal-Calderón JR, Gonzalez-Gil AM, Enriquez C, et al. Correlation of vitamin D with inflammatory cytokines, atherosclerotic parameters, and lifestyle factors in the setting of heart failure: a 12-month follow-up study. International journal of molecular sciences. 2019;20(22):5811. https://doi.org/10.3390/ijms20225811
11. Gray PW, Goeddel DV. Structure of the human immune interferon gene. Nature. 1982;298(5877):859-63. https://doi.org/10.1038/298859a0
12. Reitman S, Frankel S. A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. American journal of clinical pathology. 1957;28(1):56-63. https://doi.org/10.1093/ajcp/28.1.56
13. Bruning JL, Kintz BL. Computational handbook of statistics: Scott, Foresman & Co; 1987.
14. Buono C, Come CE, Stavrakis G, Maguire GF, Connelly PW, Lichtman AH. Influence of interferon-γ on the extent and phenotype of diet-induced atherosclerosis in the LDLR-deficient mouse. Arteriosclerosis, thrombosis, and vascular biology. 2003;23(3):454-60.
https://doi.org/10.1161/01.ATV.0000059419.11002.6E
15. Khanolkar S, Hirani S, Mishra A, Vardhan S, Hirani S, Prasad R, et al. Exploring the role of vitamin D in atherosclerosis and its impact on cardiovascular events: a comprehensive review. Cureus. 2023;15(7).
https://doi.org/10.7759/cureus.42470
16. Kamil RM, Albadry MAZ, Yaseen II, Al-fahham AA. Aminotransaminases: Structures, Functions and Clinical Significance. International Journal of Health & Medical Research. 2024;3(6):409-13. https://doi.org/10.58806/ijhmr.2024.v3i06n25
17. Rahmani J, Miri A, Namjoo I, Zamaninour N, Maljaei MB, Zhou K, et al. Elevated liver enzymes and cardiovascular mortality: a systematic review and dose–response meta-analysis of more than one million participants. European journal of gastroenterology & hepatology. 2019;31(5):555-62. https://doi.org/10.1097/MEG.0000000000001353
18. Pothineni NVK, Rochlani Y, Subramany S, Kovelamudi S, Mehta JL. Hepatic interactions in atherosclerotic heart disease. The American Journal of the Medical Sciences. 2022;363(2):104-13. https://doi.org/10.1016/j.amjms.2021.07.011
19. Adamidis PS, Florentin M, Liberopoulos E, Koutsogianni AD, Anastasiou G, Liamis G, et al. Association of alkaline phosphatase with cardiovascular disease in patients with dyslipidemia: A 6-year retrospective study. Journal of Cardiovascular Development and Disease. 2024;11(2):60. https://doi.org/10.3390/jcdd11020060
20. Kerner A, Avizohar O, Sella R, Bartha P, Zinder O, Markiewicz W, et al. Association between elevated liver enzymes and C-reactive protein: possible hepatic contribution to systemic inflammation in the metabolic syndrome. Arteriosclerosis, thrombosis, and vascular biology. 2005;25(1):193-7. https://doi.org/10.1161/01.ATV.0000148324.63685.6a
21. Baker LA. Oxidized LDL and risk of coronary heart disease. Tikrit Journal of Pure Science. 2018;22(2):82-91. https://doi.org/10.25130/tjps.v22i2.631
22. Lai Z, Liu Y, Huang M, Li L, Li Z, Su J, et al. Associations between Atherosclerosis and elevated serum alkaline phosphatase in patients with coronary artery disease in an inflammatory state. Heart, Lung and Circulation. 2023;32(9):1096-106. https://doi.org/10.1016/j.hlc.2023.05.012